Your email has been successfully added to our mailing list.

×
0 -0.00952380952380949 0 0.0476190476190476 0.10952380952381 0.0752380952380953 0 0.0466666666666667
Stock impact report

Iovance Biotherapeutics GAAP EPS of -$0.28 beats by $0.02, revenue of $58.6M beats by $4.78M [Seeking Alpha]

Iovance Biotherapeutics, Inc. (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
Company Research Source: Seeking Alpha
More on Iovance Biotherapeutics Iovance Biotherapeutics: Moving To The Next Phase Iovance Therapeutics: Historic Product, Tough Commercial Outlook Iovance's Tumor-Fighting TILs Are Just Warming Up (Rating Upgrade) Iovance Biotherapeutics Q3 2024 Earnings Preview UBS launches SMID cap biotechs with cancer, autoimmunity in focus Recommended For You Comments More Trending News Show less Read more
Impact Snapshot
Event Time:
IOVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IOVA alerts
Opt-in for
IOVA alerts

from News Quantified
Opt-in for
IOVA alerts

from News Quantified